GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 034331
Of the Field

PEGS Boston Summit 2026

P

EGS Boston Summit is the essential conference for streamlining biologics development. For over 20 years, it has been the go-to event for protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research. New in 2026 is a dedicated focus on peptides, highlighting their therapeutic power and innovations in de…

Visit the official site
12Voices
7Underwriters
0Exhibitors
0On the bill · sessions
19Companies · in total
§I

The Voices

Programmed at PEGS, in alphabetical order.
Christopher Langmead, PhD
AI-Driven Molecular Design · Danaher Corporation
James A. Wells, PhD
Professor · University of California, San Francisco
Jamie Spangler, PhD
Associate Professor · Johns Hopkins University
Joshua Meier, PhD
Co-Founder · Chai Discovery
Kipp Weiskopf, MD, PhD
Head of Antibody Therapeutics and Biologics, Cancer Research Institute · Beth Israel Deaconess Medical Center
Maria Wendt, PhD
Global Head, Preclinical Computational Innovation Strategy Research Platforms, R&D · Sanofi
Martin Pacesa, PhD
Assistant Professor, Pharmacology · University of Zurich
Michel Sadelain, MD, PhD
Director, Columbia University Initiative in Cell Engineering and Therapy (CICET); Director, Cell Therapy Initiative, Herbert Irving Comprehensive Cancer Center; Professor of Medicine · Columbia University Irving Medical Center
Rebecca Croasdale-Wood, PhD
Senior Director, Augmented Biologics Discovery & Design, Biologics Engineering, Oncology · AstraZeneca
Surge Biswas, PhD
Founder & CEO · Nabla Bio
Timothy Whitehead, PhD
Professor · University of Colorado
Xin Zhou, PhD
Assistant Professor · Harvard Medical School
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Ablexis
FairJourney Biologics
Genscript
Integral Molecular
Nona Biosciences
Nuclera
Thermo Fisher
Intermission
Part the Second · For the Buyer

An audience of 19 companies, parsed from the program.

“Nineteen companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
0All threespeak · spons · exh
7Sponsoringsponsor only
0Exhibitingexhibitor only
12Speakingspeaker only
№ 02Fig. 02 — The Voices, by Seniority

42% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite18%
  • Founder / Owner18%
  • Director / Head of325%
  • Research / Science18%
  • Other roles650%

Of 12 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01AblexisSp
  2. 02FairJourney BiologicsSp
  3. 03GenscriptSp
  4. 04Integral MolecularSp
  5. 05Nona BiosciencesSp
  6. 06NucleraSp
  7. 07Thermo FisherSp
  8. 08AstraZeneca1V
  9. 09Beth Israel Deaconess Medical Center1V
  10. 10Chai Discovery1V
  11. 11Columbia University Irving Medical Center1V
  12. 12Danaher Corporation1V
  13. 13Harvard Medical School1V
  14. 14Johns Hopkins University1V
№ 04Fig. 04 — By Tier
unspecified7
100% of 7